These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37354038)
21. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas. Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933 [TBL] [Abstract][Full Text] [Related]
22. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas. Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554 [TBL] [Abstract][Full Text] [Related]
23. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas. Gupta S; Erickson LA Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159 [TBL] [Abstract][Full Text] [Related]
24. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318 [TBL] [Abstract][Full Text] [Related]
25. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324 [TBL] [Abstract][Full Text] [Related]
26. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations. Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441 [TBL] [Abstract][Full Text] [Related]
27. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761 [TBL] [Abstract][Full Text] [Related]
28. Malignant head and neck paragangliomas in SDHB mutation carriers. Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579 [TBL] [Abstract][Full Text] [Related]
30. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Astuti D; Latif F; Dallol A; Dahia PL; Douglas F; George E; Sköldberg F; Husebye ES; Eng C; Maher ER Am J Hum Genet; 2001 Jul; 69(1):49-54. PubMed ID: 11404820 [TBL] [Abstract][Full Text] [Related]
31. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Papathomas TG; Oudijk L; Persu A; Gill AJ; van Nederveen F; Tischler AS; Tissier F; Volante M; Matias-Guiu X; Smid M; Favier J; Rapizzi E; Libe R; Currás-Freixes M; Aydin S; Huynh T; Lichtenauer U; van Berkel A; Canu L; Domingues R; Clifton-Bligh RJ; Bialas M; Vikkula M; Baretton G; Papotti M; Nesi G; Badoual C; Pacak K; Eisenhofer G; Timmers HJ; Beuschlein F; Bertherat J; Mannelli M; Robledo M; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger RR Mod Pathol; 2015 Jun; 28(6):807-21. PubMed ID: 25720320 [TBL] [Abstract][Full Text] [Related]
32. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730 [TBL] [Abstract][Full Text] [Related]
38. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study. Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715 [TBL] [Abstract][Full Text] [Related]
39. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C; JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326 [TBL] [Abstract][Full Text] [Related]